HRT Financial’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-51,039
Closed -$290K 2830
2025
Q1
$290K Buy
+51,039
New +$520K ﹤0.01% 1793
2024
Q3
Sell
-119,487
Closed -$1.6M 2598
2024
Q2
$1.6M Buy
119,487
+72,292
+153% +$2.16M 0.01% 819
2024
Q1
$2.19M Buy
47,195
+39,477
+511% +$2.04M 0.01% 532
2023
Q4
$521K Sell
7,718
-36,432
-83% -$2.23M ﹤0.01% 1338
2023
Q3
$3.2M Buy
+44,150
New +$3.53M 0.03% 438
2023
Q2
Sell
-9,164
Closed -$487K 2638
2023
Q1
$487K Buy
+9,164
New +$581K 0.01% 1410
2022
Q4
Sell
-11,368
Closed -$1.42M 2616
2022
Q3
$1.42M Buy
+11,368
New +$1.35M 0.02% 738
2022
Q2
Sell
-190,064
Closed -$30.6M 3102
2022
Q1
$30.6M Buy
+190,064
New +$37M 0.23% 53
2021
Q4
Sell
-5,831
Closed -$2.7M 3368
2021
Q3
$2.7M Buy
+5,831
New +$2.84M 0.02% 556

Other funds holding DNA